| 5XFAD | 5 familial AD mutations |
| ABCG2 | ATP-binding cassette sub-family G member 2 |
| ABCG4 | ATP-binding cassette sub-family G member 4 |
| AD | Alzheimer’s disease |
| AQP4 | Aquaporin 4 |
| Aβ | Amyloid-β |
| BBB | Blood-brain barrier |
| CA1 | Cornu ammonis 1 |
| CAA | Cerebral amyloid angiopathy |
| CNS | Central nervous system |
| CSF | Cerebrospinal fluid |
| CT | Computed tomography |
| ELISA | Enzyme-linked immunosorbent assay |
| GFAP | Glial fibrillary acidic protein |
| GLUT1 | Glucose transporter 1 |
| HPLC | High performance liquid chromatography |
| HUVEC | Human umbilical vein endothelial cell |
| ISF | Interstitial fluid |
| JAM | Junctional adhesion molecule |
| LAM | Leukocyte adhesion molecule |
| LRP1 | Low-density lipoprotein receptor-related protein 1 |
| MAGUK | Membrane-associated guanylate kinases |
| MCI | Mild cognitive impairment |
| MRI | Magnetic resonance imaging |
| mRNA | Messenger RNA |
| PDGFRβ | Platelet-derived growth factor receptor β |
| PET | Positron emission tomography |
| P-gp | P-glycoprotein |
| RAGE | Receptor for advanced glycation end products |
| TJ | Tight junction |
| VE-cadherin | Vascular endothelial-cadherin |
| ZO-1 | Zonula occludens-1 |